covid_19-_medidas_de_salud_publica_y_prevencion
Administrador de Ficheros
Espacios de nombres
Escoge "espacio de nombre"
Archivos Multimedia
Ficheros en wiki:vacunas:seguridad_vacunas_y_efectos_secundarios
- a_case_report_multifocal_necrotizing_encephalitis_and_myocarditis_after_bnt162b2_mrna_vaccination_against_covid-19.png
- 757×312
- 2023/04/28 19:45
- 18.9 KB
- acute_severe_ulcerative_colitis_after_mrna_coronavirus_disease_2019_vaccination.pdf
- 2023/04/28 19:45
- 655.9 KB
- adverse_effects_of_covid-19_mrna_vaccines_the_spike_hypothesis.pdf
- 2023/04/28 19:45
- 1.4 MB
- adverse_effects_of_covid-19_vaccines_and_measures_to_prevent_them_japan.pdf
- 2023/04/28 19:45
- 940.2 KB
- adverse_events_following_covid‐19_mrna_vaccines_a_systematic_review.pdf
- 2023/09/26 22:27
- 1 MB
- analys_1.pdf
- 2023/04/28 19:45
- 792.6 KB
- anti-nucleocapsid_antibodies_following_sars-cov-2_infection_in_the_blinded_phase_of_the_mrna-.pdf
- 2023/04/28 19:45
- 731.3 KB
- association_between_different_types_of_covid-19_vaccines_and_menstrual_cycle_patterns.pdf
- 2023/11/05 19:56
- 926.5 KB
- association_of_cerebral_venous_thrombosis_with_mrna_covid-19_vaccines.pdf
- 2023/04/28 19:45
- 821.1 KB
- autopsy_findings_in_cases_of_fatal_covid-19_vaccine-induced_myocarditis.pdf
- 2024/02/01 22:31
- 1.5 MB
- cappelletti_montano_b_a_comparative_analysis_on_serious_adverse.pdf
- 2023/06/18 22:34
- 3.6 MB
- cardiovascular_effects_of_the_bnt162b2_mrna_covid-19_vaccine_in_adolescents.pdf
- 2023/04/28 19:46
- 622.5 KB
- cardiovascular_manifestation_of_the_bnt162b2_mrna_covid-19_vaccine_in_adolescents.pdf
- 2023/04/28 19:46
- 1.1 MB
- changes_of_ecg_parameters_after_bnt162b2_vaccine_in_the_senior_high_school_students.pdf
- 2023/04/28 19:46
- 841.2 KB
- circulating_spike_protein_detected_in_post_covid-19_mrna_vaccine_myocarditis.pdf
- 2023/04/28 19:46
- 1.1 MB
- co-van_study_covid-19_vaccine_associated_neurological_diseases.pdf
- 2023/04/28 19:46
- 2.3 MB
- co1f00_1.pdf
- 2024/05/14 19:38
- 3.6 MB
- corona_virus_disease-19_vaccine_associated_autoimmune_disorders.pdf
- 2023/04/28 19:46
- 378.9 KB
- covid_shots_are_the_deadliest_vaccines_in_medical_history_mercola.pdf
- 2023/04/28 19:46
- 166.4 KB
- covid-19_hospital_admissions_and_deaths_after_vaccines_first_cdosis_scotland.pdf
- 2023/04/28 19:46
- 618 KB
- covid-19_vaccination_and_neurological_manifestations.pdf
- 2023/04/28 19:46
- 703 KB
- covid-19_vaccination-related_myocarditis_a_korean_nationwide_study.pdf
- 2023/07/05 22:41
- 1 MB
- covid-19_vaccination-related_small_vessel_vasculitis_with_multiorgan_involvement.pdf
- 2023/09/15 19:08
- 1.7 MB
- covid-19_vaccine_surveillance_report_uk.pdf
- 2023/04/28 19:46
- 6.1 MB
- covid-19_vaccines_proof_of_lethality._over_one_thousand_scientific_studies.pdf
- 2023/04/28 19:46
- 470.7 KB
- covid-vaccine-mortality-southern-hemisphere-cor.pdf
- 2024/05/09 18:04
- 23.5 MB
- covid19_rna_based_vaccines_and_the_risk_of_prion_disease_1503.pdf
- 2023/04/28 19:46
- 326 KB
- efectos_adversos_en_la_c._de_madrid.pdf
- 2023/04/28 19:46
- 481.3 KB
- efectos_secundarios_vacunas_en_alemania_hasta_el_21-3-2020.pdf
- 2023/04/28 19:46
- 1002.6 KB
- epidemiology_of_myocarditis_and_pericarditis_following_mrna_vaccines_in_ontario.pdf
- 2023/04/28 19:46
- 364.9 KB
- estimating_the_number_of_covid_vaccines_deaths.pdf
- 2023/04/28 19:46
- 1.9 MB
- estudio_isreli_anticuerpos_en_vacunados_y_no_vacunados.odt
- 2023/04/28 19:46
- 21 KB
- fatal_myocarditis_following_covid-19_mrna_immunization_child.pdf
- 2024/06/13 17:42
- 7 MB
- graves_disease_after_mrna_covid-19_vaccination.pdf
- 2023/07/16 20:22
- 2 MB
- increa_1.pdf
- 2023/04/28 19:46
- 2.7 MB
- increa_2.pdf
- 2023/04/28 19:46
- 2.7 MB
- increased_emergency_cardiovascular_events_among_under-40_population_in_israel.pdf
- 2023/08/18 17:47
- 2.7 MB
- informe-farmacovigilancia-febrero-2021.pdf
- 2023/04/28 19:46
- 575.8 KB
- informe-farmacovigilancia-junio-2021.pdf
- 2023/04/28 19:46
- 683.5 KB
- insights_into_new-onset_autoimmune_diseases_after_covid-19_vaccination.pdf
- 2023/04/28 19:46
- 1.1 MB
- israel_conversacion_sobre_efectos_secundarios.pdf
- 2023/04/28 19:46
- 136 MB
- myocarditis_and_pericarditis_after_vaccination_for_covid-19.pdf
- 2023/06/26 18:09
- 198.5 KB
- neuropathic_symptoms_with_sars-cov-2_vaccination.pdf
- 2023/11/27 20:04
- 3.7 MB
- new_diagnosis_of_multiple_esclerosis.png
- 755×277
- 2023/06/10 11:40
- 55.6 KB
- new_diagnosis_of_multiple_sclerosis_in_the_setting_of_mrna_covid-19_vaccine_exposure.pdf
- 2023/06/10 11:41
- 928.1 KB
- polymyalgia_rheumatica_following_covid-19_vaccination.pdf
- 2023/05/15 22:50
- 200 KB
- potential_health_risks_of_mrna-based_vaccine_therapy_a_hypothesis.pdf
- 2023/04/28 19:46
- 744.1 KB
- r18hs017045-lazarus-final-report-2011_electronic_support_for_public_health_vaccine_adverse.pdf
- 2023/04/28 19:46
- 96.2 KB
- real‐world_evidence_s_is_consistent_with_with_reactivation_of_the_varicella-zoster_virus.pdf
- 2023/04/28 19:46
- 197.3 KB
- risk_of_myocarditis_following_sequential_covid-19_vaccinations_by_age_and_sex.pdf
- 2023/04/28 19:46
- 1.6 MB
- sars-cov-2_vaccination_and_myocarditis_in_a_nordic_cohort_study_of_23_million_residents.pdf
- 2023/04/28 19:46
- 512.7 KB
- serious_adverse_events_of_special_interest_following_mrna_covid-19.pdf
- 2023/04/28 19:46
- 393.4 KB
- serious_adverse_events_of_special_interest_following_mrna_vaccination_in_randomized_trials.pdf
- 2023/04/28 19:46
- 290.4 KB
- serious_adverse_events_of_special_interest_following.pdf
- 2023/04/28 19:46
- 290.4 KB
- serious_harms_of_the_covid-19_vaccines_a_systematic_review.pdf
- 2023/04/28 19:46
- 195.9 KB
- sex-specific_differences_in_myocardial_injury_incidence_after_covid-19_mrna-1273_booster.pdf
- 2023/08/07 20:27
- 1.5 MB
- the_covid_19_inoculations_more_harm_than_good_rev_dec_16_2021.pdf
- 2023/04/28 19:46
- 8 MB
- the_safety_of_covid-19_vaccinations_we_should_rethink.pdf
- 2023/04/28 19:46
- 356.5 KB
- unexpected_vaginal_bleeding_and_covid-19_vaccination_in_nonmenstruating_women.pdf
- 2023/10/02 21:29
- 4.6 MB
- vaccine-surveillance-report-week-3-2022.pdf
- 2023/04/28 19:46
- 4.8 MB
- vaccines_against_covid-19_venous_thromboembolism_and_thrombocytopenia._laporte.pdf
- 2023/04/28 19:46
- 169.3 KB
Fichero
- Ver
- Historial
- Fecha:
- 2023/04/28 19:45
- Nombre del archivo:
- analysis_of_asymptomatic_and_presymptomatic_transmission_germany.pdf
- Tamaño:
- 3MB
- Referencias para:
- start
- transmision_asintomaticos
- vehiculos_de_transmision
covid_19-_medidas_de_salud_publica_y_prevencion.txt · Última modificación: 2023/04/28 19:26 por 127.0.0.1